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found suitable for the diagnosis of 
OROV infections in the acute phase. 
Thus, a combination of a systematic 
surveillance for acute febrile illnesses 
and efﬁ  cient laboratory diagnosis for 
OROV resulted in the discovery of an 
outbreak, which would probably have 
been overlooked if it had occurred in 
any region simultaneously with large 
dengue outbreaks or in the absence 
of laboratory diagnosis. The cases of 
OROV fever reported here likely rep-
resent a small portion of the cases; a 
much higher number of cases prob-
ably occurred in Manaus during the 
study period.
The clinical characteristics of 
most cases of OROV fever in this 
outbreak were similar to previously 
reported descriptions of the illness. 
Notably, however, 20 (15.5%) pa-
tients from Manaus had spontaneous 
hemorrhagic phenomena (petecchiae, 
epistaxis, and gingival bleeding) that 
had not previously been described in 
OROV fever (4–6). Moreover, symp-
toms of involvement of the central 
nervous system were not observed.
In recent years, the area of cir-
culation and the epidemic potential 
of OROV have increased, and this 
virus has emerged as a public health 
problem in Brazil and other countries 
in the Americas. Presently, OROV 
is the most common of the Brazilian 
zoonotic arboviruses infecting humans 
(7). Further evidence of the spread of 
OROV was its isolation in 2003 from 
a small primate, a marmoset (Cal-
lithrix), in the state of Minas Gerais in 
southeast Brazil, far from the Amazon 
region (8). Considering that midges 
(Culicoides paraensis) occur in most 
low altitude areas of the Americas, it 
is conceivable that environmental de-
struction and climate changes could 
result in OROV outbreaks in the large 
cities of Brazil, as well as in other parts 
of the Western Hemisphere (9).
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Identical Strains of 
Borrelia hermsii in 
Mammal and Bird
To the Editor: On August 5, 
1994, a northern spotted owl, Strix 
occidentalis caurina, was found 
dead in Kittitas County, Washington, 
USA (1). A thorough investigation 
and necropsy identiﬁ  ed the probable 
cause of death to be a spirochete in-
fection. The organisms were seen in 
sections of the bird’s liver with use of 
modiﬁ  ed Steiner silver stain and mi-
croscopy. DNA was extracted from 
the infected liver, and PCR–DNA se-
quencing of the 16S ribosomal RNA 
(rRNA) locus identiﬁ  ed the bacterium 
as a relapsing fever spirochete related 
most closely to Borrelia hermsii (1). 
The lack of additional data surround-
ing this case precluded Thomas et al. 
from concluding that this spirochete 
2064  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 12, December 2009LETTERS
infecting the owl was B. hermsii (1). 
Yet, in a subsequent analysis using the 
intergenic spacer region, the owl spi-
rochete was included with isolates of 
B. hermsii (2).
To investigate the distribution and 
prevalence of B. hermsii , during the 
summer of 2008, we began a study at 
Flathead Lake, Lake County, Montana, 
USA, where 9 persons have contract-
ed relapsing fever since 2002 (3–5). A 
blood smear from 1 pine squirrel (Ta-
miasciurus hudsonicus) captured July 
9 at Yellow Bay on the east shore of the 
lake (elevation 887 m; geographic co-
ordinates 47°52′35′′N, 114°01′54′′W) 
contained spirochetes detected when 
stained with Giemsa and examined 
by microscopy (600× brightﬁ  eld with 
oil immersion). Whole blood from the 
squirrel contained live spirochetes vis-
ible by dark-ﬁ  eld microscopy, and ≈50 
μL of this blood was injected intrap-
eritoneally into a laboratory mouse. 
The next day, a few spirochetes were 
observed in the peripheral blood of the 
mouse, and during the next 3 days, the 
density of spirochetes increased. We 
used intracardiac puncture to collect 
blood from the mouse for spirochete 
isolation in BSK-H medium (Sigma-
Aldrich, St Louis, MO, USA) and for 
analysis by PCR and DNA sequencing 
of multiple bacterial loci as described 
elsewhere (4,6).
 The spirochetes observed in 
the squirrel’s blood failed to grow in 
BSK-H medium after passage in the 
laboratory mouse; however, we ac-
quired DNA sequences from infected 
squirrel and mouse blood from PCR 
amplicons for 6 spirochete loci in-
cluding 16S rDNA, ﬂ  aB, gyrB, glpQ, 
IGS, and vtp. Sequences for the loci 
were each aligned with homologous 
sequences from other borrelia in our 
collection, and each locus grouped 
the spirochete within the 2 genomic 
groups of B. hermsii described previ-
ously (4,6). The unique squirrel spiro-
chete differed from all other B. hermsii 
identiﬁ  ed in our previous studies; deep 
branches in each phylogram grouped 
the spirochete more closely with B. 
hermsii genomic group I than with ge-
nomic group II (data not shown).
Next, we compared the sequenc-
es from the squirrel spirochete with 
those available in the National Cen-
ter for Biotechnology Information 
database (www.ncbi.nlm.nih.gov), 
including those sequences reported 
for the spirochete found in the spot-
ted owl (AY515269.1, AF116903.1,   
AF116904.1) (1,2). The 3 trimmed 
and aligned sequences for the 16S 
rDNA (1,290 bases), ﬂ  aB (467 bas-
es), and IGS (665 bases) from the 
squirrel spirochete were identical 
to those of the owl spirochete; no 
base differences were found among 
the 2,422 bases compared. We also 
examined DNA extracted from the 
spotted owl’s liver during the ﬁ  rst in-
vestigation (1) (provided by Alan G. 
Barbour). We successfully PCR am-
pliﬁ  ed most of the 16S rDNA and the 
complete  ﬂ  aB,  gyrB,  glpQ, and vtp 
genes from the owl spirochete DNA 
and determined their sequences. The 
complete sequences of the ﬁ  rst 4 loci 
from the owl and squirrel spirochetes 
were identical and differed from all 
other B. hermsii sequences. A phylo-
gram of the concatenated sequences 
totaling 5,188 bases demonstrated 
that the owl and pine squirrel spiro-
chetes were identical and were diver-
gent members of B. hermsii genomic 
group I (Figure).
Finding the same strain of B. 
hermsii, separated by ≈525 km, in a 
pine squirrel and a spotted owl demon-
strates a broader geographic distribu-
tion and host range for this spirochete 
than what could have been envisaged 
previously. The possible role of birds 
as hosts for the vector Ornithodoros 
hermsi ticks has been demonstrated 
elsewhere (4). Given the ecologic 
overlap of pine squirrels and conifer-
ous forest-dwelling birds, we believe 
that the previous ﬁ  nding of the infect-
ed spotted owl is likely not an isolated 
event. Instead, it may represent a tick–
spirochete cycle for B. hermsii that 
includes a broader host range for this 
group of relapsing fever spirochetes 
than previously appreciated.
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Figure. Phylogram based on the alignment of the concatenated DNA sequences containing 
the 16S rDNA, ﬂ  aB, gyrB, and glpQ loci for 6 isolates (DAH, GAR, ALL, LAK-1, MTW-2, 
and YOR) and infected tissues from the owl (OWL) and pine squirrel (YB-Th-60) of Borrelia 
hermsii. The same loci from B. turicatae 91E135 were used for the outgroup. New DNA 
sequences determined for the owl and pine squirrel spirochetes are available in GenBank 
(accession nos. GQ175059–GQ175068). Scale bar indicates number of base substitutions 
(×100).LETTERS
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Mycobacterium 
bovis and 
M. tuberculosis 
in Goats, Nigeria 
To the Editor: Documentation 
of possible tuberculosis (TB) in goats 
in Nigeria was reported by Ojo (1) on 
the basis of gross lesions without cul-
ture conﬁ  rmation. Livestock owners 
in Nigeria normally graze cattle and 
goats together, and this practice poses 
a high risk for transmission of bovine 
TB among these animals (1). This 
practice is especially a threat to goats 
in Nigeria because several reports 
have described bovine TB in cattle 
in Nigeria (2–5). However, reports of 
diagnosis of TB in goats in Nigeria 
are lacking.
Molecular epidemiologic tech-
niques such as deletion typing and 
spoligotyping have been used to char-
acterize members of the Mycobac-
terium tuberculosis complex (MTC) 
and to provide information on trans-
mission of mycobacterial diseases be-
tween animals and humans (6). How-
ever, because of limited resources and 
lack of expertise, these techniques are 
not commonly used in most develop-
ing nations such as Nigeria, where TB 
is endemic (3).
Because slaughterhouses provide 
excellent opportunities for detect-
ing diseases of economic and public 
health importance, we investigated the 
presence of mycobacteria in slaugh-
tered goats with lesions suggestive of 
TB. The investigation was conducted 
at the Bodija Municipal Abattoir in 
Ibadan in southwestern Nigeria over 
a period of 6 months. Slaughtered 
goats were obtained from local herds 
and herds in northern Nigeria. A total 
of 10,389 male and female goats of 2 
breeds (West African Dwarf and Red 
Sokoto) and 1–2 years of age were 
slaughtered; 1,387 were inspected for 
gross lesions of TB.
Of 1,387 animals screened, 62 
(4.47%) had lesions suggestive of 
TB in the liver, lungs, and mesenter-
ic lymph nodes. Five (0.36%) goats 
were conﬁ   rmed positive by culture 
as described (2). Deletion typing (6) 
with the RD9 deletion was used to 
distinguish M. tuberculosis from other 
members of the MTC. Those isolates 
with a deletion in this region were fur-
ther investigated with primers speciﬁ  c 
for RD4. This reaction distinguishes 
between M. bovis, M. caprae, and oth-
er members of the MTC. Spoligotyp-
ing was performed as described (7) to 
type an M. tuberculosis isolate from a 
goat after identiﬁ  cation of this bacte-
rium by deletion typing.
We isolated 4 strains of M. bovis 
and 1 strain of M. tuberculosis from 
the goats (Table). Spoligotyping 
identiﬁ  ed the M. tuberculosis isolate 
as belonging to the East African In-
dian (EAI)–5 family in the SpolDB4 
database. All M. bovis isolates were 
M. bovis bovis, not M. bovis caprae, 
according to their deletion typing 
proﬁ  le (6). One M. bovis isolate was 
obtained from a male goat; the 3 re-
maining M. bovis isolates and the M. 
tuberculosis isolate were obtained 
from female goats.
Epidemiologic inferences can be 
made from the results of our study. 
First,  M.  bovis, which is naturally 
found in cattle, was isolated from 4 
slaughtered goats. Although M.  bo-
vis caprae was the M.  bovis variant 
most frequently isolated from goats in 
some areas (8), in our study, only M. 
bovis bovis was isolated. This ﬁ  nd-
ing is consistent with results reported 
by Crawshaw et al. (9), and suggests 
transmission from cattle, rather than 
transmission from the goat reservoir. 
Second, because the infected goats 
were adult females, infection may be 
transmitted to their offspring. Third, M. 
tuberculosis was isolated from a goat. 
Its presence in this goat may have been 
caused by direct transmission from hu-
mans because this bacterium may be a 
natural pathogen of humans.
Transmission caused by close 
cohabitation of goats and humans 
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